XERS
Price:
$2.51
Market Cap:
$373.99M
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its pr...[Read more]
Industry
Biotechnology
IPO Date
2018-06-21
Stock Exchange
NASDAQ
Ticker
XERS
According to Xeris Biopharma Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.26. This represents a change of 11.64% compared to the average of 2.02 of the last 4 quarters.
The mean historical Current Ratio of Xeris Biopharma Holdings, Inc. over the last ten years is 5.96. The current 2.26 Current Ratio has changed 3.68% with respect to the historical average. Over the past ten years (40 quarters), XERS's Current Ratio was at its highest in in the September 2018 quarter at 16.53. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
5.96
Median
3.97
Minimum
1.64
Maximum
13.13
Discovering the peaks and valleys of Xeris Biopharma Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 40.66%
Maximum Annual Current Ratio = 13.13
Minimum Annual Increase = -66.57%
Minimum Annual Current Ratio = 1.64
Year | Current Ratio | Change |
---|---|---|
2023 | 1.64 | -35.31% |
2022 | 2.54 | 0% |
2021 | 2.54 | 40.66% |
2020 | 1.80 | -66.57% |
2019 | 5.40 | -53.44% |
2018 | 11.59 | 27.87% |
2017 | 9.06 | -30.95% |
The current Current Ratio of Xeris Biopharma Holdings, Inc. (XERS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.24
5-year avg
2.78
10-year avg
5.96
Xeris Biopharma Holdings, Inc.’s Current Ratio is greater than Protalix BioTherapeutics, Inc. (1.33), greater than Seres Therapeutics, Inc. (1.38), less than Cidara Therapeutics, Inc. (4.25), less than ImmunityBio, Inc. (3.91), less than Galera Therapeutics, Inc. (5.63), less than Mereo BioPharma Group plc (6.07), less than Terns Pharmaceuticals, Inc. (21.02), less than PDS Biotechnology Corporation (3.84), less than Inozyme Pharma, Inc. (9.84), less than HOOKIPA Pharma Inc. (3.86), less than X4 Pharmaceuticals, Inc. (6.07), less than Day One Biopharmaceuticals, Inc. (4.09), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Elevation Oncology, Inc. (41.10), less than Hepion Pharmaceuticals, Inc. (5.62),
Company | Current Ratio | Market cap |
---|---|---|
1.33 | $73.54M | |
1.38 | $145.36M | |
4.25 | $80.52M | |
3.91 | $2.35B | |
5.63 | $4.08M | |
6.07 | $664.26M | |
21.02 | $549.60M | |
3.84 | $107.88M | |
9.84 | $312.42M | |
3.86 | $159.50M | |
6.07 | $109.78M | |
4.09 | $1.25B | |
1.03 | $188.18K | |
41.10 | $36.94M | |
5.62 | $4.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xeris Biopharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xeris Biopharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Xeris Biopharma Holdings, Inc.'s Current Ratio?
How is the Current Ratio calculated for Xeris Biopharma Holdings, Inc. (XERS)?
What is the highest Current Ratio for Xeris Biopharma Holdings, Inc. (XERS)?
What is the 3-year average Current Ratio for Xeris Biopharma Holdings, Inc. (XERS)?
What is the 5-year average Current Ratio for Xeris Biopharma Holdings, Inc. (XERS)?
How does the current Current Ratio for Xeris Biopharma Holdings, Inc. (XERS) compare to its historical average?